Drug Database
Back to search

Poland· PL-100228757

Agapurin SR 400

A pentoxifylline product containing pentoxifyllinum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.

ATC C04AD03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAgapurin SR 400ATCC04AD03REGISTER NO.PL-100228757PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pentoxifyllinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pentoxifylline is registered in 12 of 19 countries.

Countries holding a registration under ATC C04AD03 (pentoxifylline), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search pentoxifylline products by name

Pentoxifylline · ATC C04AD03

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Pentoxifyllinum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
C04AD03
ATC class
Pentoxifylline
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909997214467
  • gtin
    05909997214474
  • gtin
    05909997214481

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

435 interactions on record for pentoxifylline.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pentoxifylline against other medicinesHow interaction checks work

Pentoxifylline · interactions on record

435 records

  • 4 severe
  • 252 moderate
  • 179 info

Most severe, free to view

  • CimetidineA02BA01moderate
  • PapaverineA03AD01moderate
  • Obeticholic acidA05AA04moderate
  • MannitolA06AD16moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pentoxifylline in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pentoxifylline products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Pentomer Retard, Pentoxi Retard
  • Belgium · Torental
  • Bulgaria · Агапурин, Агапурин Sr
  • Cyprus · Angiopent Retard, Tarοntal
  • Czechia · Agapurin, Pentomer Retard
  • Germany · Pentoxifyllin 1 A Pharma, Pentoxifyllin Ratiopharm
  • Estonia · Pentilin, Vasonit Retard
  • Spain · Elorgan, Hemovás
  • France · Pentoxifylline Lp Biogaran, Pentoxifylline Lp Eg
  • United Kingdom (Northern Ireland) · Pentoxifylline Neuraxpharm Uk
  • Greece · Tarontal
  • Croatia · Pentilin, Trental
  • Hungary · Chinotal, Pentoxyl
  • Italy · Trental
  • Lithuania · Agapurin, Pentilin
  • Luxembourg · Pentoxifylline Ratiopharm, Torental
  • Latvia · Pentilin, Polfilin
  • Netherlands · Trental
  • Norway · Trental
  • Portugal · Pentoxifilina Generis, Trental
  • Romania · Angiopent Retard, Pentoxi Retard
  • Slovenia · Pentilin
  • Slovakia · Agapurin, Agapurin Sr

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/09cb992e-99eb-4eed-bebf-3875b27089e9
GET /v1/drugs/09cb992e-99eb-4eed-bebf-3875b27089e9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki o przedłużonym uwalnianiu",
  "source": "urpl",
  "strength": "400 mg",
  "packaging": "05909997214467 ¦ Rp ¦ 80886\n20 tabl.\n05909997214474 ¦ Rp ¦ 80887\n50 tabl.\n05909997214481 ¦ Rp ¦ 80888\n100 tabl.",
  "substance": null,
  "common_name": "Pentoxifyllinum",
  "pl_product_id": "100228757",
  "pozwolenie_nr": "577/12",
  "auth_procedure": "IR",
  "authorisation_validity": "2027-10-22"
}
API referenceMCP serverPlans

See everything about pentoxifylline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console